Dealing with the dual epidemics of HIV and TB

N. Martinson, H. Hausler, G. J. Churchyard, S. D. Lawn

Research output: Contribution to journalArticle

Abstract

This article summarises three of the presentations made at a TB symposium at the recent 2nd South African AIDS Conference in Durban. HIV infection is the most potent risk factor for active tuberculosis (TB) and and as a result TB has become the leading life-threatening opportunistic infection. In addition it has changed the epidemiology of TB in high HIV prevalence, settings; HIV makes the diagnosis of TB more difficult and is associated with a far higher risk of death. Preventive treatment regimens in HIV-infected adults have been shown to be efficacious and cost effective but their widespread implementation is hampered by poor adherence, concerns about development of resistance and the potential burden to the TB control programme. Result of adult cohort studies suggest that antiretroviral treatment has a powerful preventive effect on active TB; however, successful ARV treatment does not restore immune function and TB risk to levels seen in HIV-uninfected adults. Novel strategies are therefore urgently needed to combat TB in high HIV prevalence settings.

Original languageEnglish (US)
Pages (from-to)33-35
Number of pages3
JournalSouthern African Journal of HIV Medicine
Issue number20
StatePublished - Sep 2005
Externally publishedYes

Fingerprint

Tuberculosis
HIV
Opportunistic Infections
HIV Infections
Acquired Immunodeficiency Syndrome
Epidemiology
Cohort Studies
Costs and Cost Analysis

ASJC Scopus subject areas

  • Virology
  • Public Health, Environmental and Occupational Health

Cite this

Martinson, N., Hausler, H., Churchyard, G. J., & Lawn, S. D. (2005). Dealing with the dual epidemics of HIV and TB. Southern African Journal of HIV Medicine, (20), 33-35.

Dealing with the dual epidemics of HIV and TB. / Martinson, N.; Hausler, H.; Churchyard, G. J.; Lawn, S. D.

In: Southern African Journal of HIV Medicine, No. 20, 09.2005, p. 33-35.

Research output: Contribution to journalArticle

Martinson, N, Hausler, H, Churchyard, GJ & Lawn, SD 2005, 'Dealing with the dual epidemics of HIV and TB', Southern African Journal of HIV Medicine, no. 20, pp. 33-35.
Martinson N, Hausler H, Churchyard GJ, Lawn SD. Dealing with the dual epidemics of HIV and TB. Southern African Journal of HIV Medicine. 2005 Sep;(20):33-35.
Martinson, N. ; Hausler, H. ; Churchyard, G. J. ; Lawn, S. D. / Dealing with the dual epidemics of HIV and TB. In: Southern African Journal of HIV Medicine. 2005 ; No. 20. pp. 33-35.
@article{029c64d2a63a45629fa7842d0be0603b,
title = "Dealing with the dual epidemics of HIV and TB",
abstract = "This article summarises three of the presentations made at a TB symposium at the recent 2nd South African AIDS Conference in Durban. HIV infection is the most potent risk factor for active tuberculosis (TB) and and as a result TB has become the leading life-threatening opportunistic infection. In addition it has changed the epidemiology of TB in high HIV prevalence, settings; HIV makes the diagnosis of TB more difficult and is associated with a far higher risk of death. Preventive treatment regimens in HIV-infected adults have been shown to be efficacious and cost effective but their widespread implementation is hampered by poor adherence, concerns about development of resistance and the potential burden to the TB control programme. Result of adult cohort studies suggest that antiretroviral treatment has a powerful preventive effect on active TB; however, successful ARV treatment does not restore immune function and TB risk to levels seen in HIV-uninfected adults. Novel strategies are therefore urgently needed to combat TB in high HIV prevalence settings.",
author = "N. Martinson and H. Hausler and Churchyard, {G. J.} and Lawn, {S. D.}",
year = "2005",
month = "9",
language = "English (US)",
pages = "33--35",
journal = "Southern African Journal of HIV Medicine",
issn = "1608-9693",
publisher = "South African Medical Association",
number = "20",

}

TY - JOUR

T1 - Dealing with the dual epidemics of HIV and TB

AU - Martinson, N.

AU - Hausler, H.

AU - Churchyard, G. J.

AU - Lawn, S. D.

PY - 2005/9

Y1 - 2005/9

N2 - This article summarises three of the presentations made at a TB symposium at the recent 2nd South African AIDS Conference in Durban. HIV infection is the most potent risk factor for active tuberculosis (TB) and and as a result TB has become the leading life-threatening opportunistic infection. In addition it has changed the epidemiology of TB in high HIV prevalence, settings; HIV makes the diagnosis of TB more difficult and is associated with a far higher risk of death. Preventive treatment regimens in HIV-infected adults have been shown to be efficacious and cost effective but their widespread implementation is hampered by poor adherence, concerns about development of resistance and the potential burden to the TB control programme. Result of adult cohort studies suggest that antiretroviral treatment has a powerful preventive effect on active TB; however, successful ARV treatment does not restore immune function and TB risk to levels seen in HIV-uninfected adults. Novel strategies are therefore urgently needed to combat TB in high HIV prevalence settings.

AB - This article summarises three of the presentations made at a TB symposium at the recent 2nd South African AIDS Conference in Durban. HIV infection is the most potent risk factor for active tuberculosis (TB) and and as a result TB has become the leading life-threatening opportunistic infection. In addition it has changed the epidemiology of TB in high HIV prevalence, settings; HIV makes the diagnosis of TB more difficult and is associated with a far higher risk of death. Preventive treatment regimens in HIV-infected adults have been shown to be efficacious and cost effective but their widespread implementation is hampered by poor adherence, concerns about development of resistance and the potential burden to the TB control programme. Result of adult cohort studies suggest that antiretroviral treatment has a powerful preventive effect on active TB; however, successful ARV treatment does not restore immune function and TB risk to levels seen in HIV-uninfected adults. Novel strategies are therefore urgently needed to combat TB in high HIV prevalence settings.

UR - http://www.scopus.com/inward/record.url?scp=27844529531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27844529531&partnerID=8YFLogxK

M3 - Article

SP - 33

EP - 35

JO - Southern African Journal of HIV Medicine

JF - Southern African Journal of HIV Medicine

SN - 1608-9693

IS - 20

ER -